124
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Quantification of circulating fetal DNA as a tool for potential monitoring of pregnant patients with antiphospholipid antibodies

, , , &
Pages 473-477 | Received 18 Jun 2013, Accepted 19 Apr 2014, Published online: 15 May 2014

References

  • Lo, Y. M., N. Corbette, P. F. Chamberlain, et al. (1997). Presence of fetal DNA in maternal plasma and serum. Lancet. 350: 485–487
  • Simpson, J. L. (2013). Cell-free fetal DNA and maternal serum analytes for monitoring embryonic and fetal status. Fertil. Steril. 99: 1124–1134
  • Galbiati, S., M. Smid, D. Gambini, et al. (2005). Fetal DNA detection in maternal plasma throughout gestation. Hum. Genet. 117: 243–248
  • Guibert, J., A. Benachi, A. G. Grebille, et al. (2003). Kinetics of SRY gene appearance in maternal serum: detection by real time PCR in early pregnancy after assisted reproductive technique. Hum. Reprod. 18: 1733–1736
  • Alberry, M., D. Maddocks, M. Jones, et al. (2007). Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat. Diagn. 27: 415–418
  • Al-Mufti, R., H. Hambley, G. Albaiges, et al. (2000). Increased fetal erythroblasts in women who subsequently develop pre-eclampsia. Hum. Reprod. 15: 1624–1628
  • Zhong, X. Y., W. Holzgreve, and S. Hahn. (2002). Cell-free fetal DNA in the maternal circulation does not stem from the transplacental passage of fetal erythroblasts. Mol. Hum. Reprod. 8: 864–870
  • Bischoff, F. Z., D. E. Lewis, and J. L. Simpson. (2005). Cell-free fetal DNA in maternal blood: kinetics, source and structure. Hum. Reprod. 11: 59–67
  • Tjoa, M. L., T. Cindrova-Davies, O. Spasic-Boskovic, et al. (2006). Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. Am. J. Pathol. 169: 400–404
  • Horinek, A., M. Korabecna, A. Panczak, et al. (2008). Cell-free fetal DNA in maternal plasma during physiological single male pregnancies: Methodology issues and kinetics. Fetal. Diag. Ther. 24: 15–21
  • Leung, T. N., J. Zhang, T. K. Lau, et al. (1998). Maternal plasma fetal DNA as a marker for preterm labour. Lancet. 352: 1904–1905
  • Sekizawa, A., M. Jimbo, H. Saito, et al. (2003). Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction. Am. J. Obstet. Gynecol. 188: 480–484
  • Caramelli, E., N. Rizzo, M. Concu, et al. (2003). Cell-free fetal DNA concentration in plasma of patients with abnormal uterine artery Doppler waveform and intrauterine growth restriction – a pilot study. Prenat. Diagn. 23: 367–371
  • Zhong, X. Y., W. Holzgreve, J. C. Li, et al. (2000). High levels of fetal erythroblasts and fetal extracellular DNA in the peripheral blood of a pregnant woman with idiopathic polyhydramnios: case report. Prenat. Diagn. 20: 838–841
  • Lazar, L., B. Nagy, Z. Ban, et al. (2006). Presence of cell-free fetal DNA in plasma of women with ectopic pregnancies. Clin. Chem. 52: 1599–1601
  • Lo, Y. M., T. N. Leung, M. S. Tein, et al. (1999). Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin. Chem. 45: 184–188
  • Zeybek, Y. G., T. Günel, A. Benian, et al. (2013). Clinical evaluations of cell-free fetal DNA quantities in pre-eclamptic pregnancies. J. Obstet. Gynaecol. Res. 39: 632–640
  • Zhong, X. Y., H. Laivuori, J. C. Livingston, et al. (2001). Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am. J. Obstet. Gynecol. 184: 414–419
  • Swinkels, D. W., J. B. de Kok, J. C. Hendriks, et al. (2002). Hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal DNA in maternal plasma and serum. Clin. Chem. 48: 650–653
  • Leung, T. N., J. Zhang, T. K. Lau, et al. (2001). Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin. Chem. 47: 137–139
  • Farina, A., A. Sekizawa, Y. Sugito, et al. (2004). Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patiens. Prenat. Diagn. 24: 83–86
  • Duckitt, K., and D. Harrington. (2005). Risk factors for preeclampsia at antenatal booking. Systematic review of controlled studies. BMJ. 330: 565–571
  • Hristoskova, S., W. Holzgreve, and S. Hahn. (2004). Anti-phospholipid and anti-DNA antibodies are not associated with the elevated release of circulatory fetal DNA in pregnancies affected by preeclampsia. Hypertens. Pregnancy. 23: 257–268
  • Ulcova-Gallova, Z. (2005). Antiphospholipid antibodies and reproductive failure. Chem. Immunol. Allergy. 88: 139–149
  • Subrt, I., Z. Ulcova-Gallova, K. Bibkova, et al. (2008). Recurrent pregnancy loss and frequency of eight antiphospholipid antibodies and genetic thrombophilic factors in Czech women. Am. J. Reprod. Immunol. 59: 193–200
  • Zimmermann, B., A. El-Sheikhah, K. Nicolaides, et al. (2005). Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma. Clin. Chem. 51: 1598–1604
  • Jakobsen, T. R., F. B. Clausen, L. Rode, et al. (2013). Identifying mild and severe preeclampsia in asymptomatic pregnant women by levels of cell-free fetal DNA. Transfusion. 53: 1956–1964
  • Canti, V., M. T. Castiglioni, S. Rosa, et al. (2012). Pregnancy outcomes in patients with systemic autoimmunity. Autoimmunity. 45: 169–175
  • Carp, H. J. A., and Y. Shoenfeld. (2007). Recurrent spontaneous abortions in antiphospholipid syndrome: natural killer cells-an aditional mechanism in a multi factorial process. Rheumatology (Oxford). 46: 1517–1519
  • Ulcova-Gallova, Z. (2005). Antiphospholipid antibodies and reproductive failure. Chem. Immunol. Allergy. 88: 139–149
  • Shoenfeld, Y., H. J. Carp, V. Molina, et al. (2006). Autoantibodies and prediction of reproductive failure. Am. J. Reprod. Immunol. 56: 337–344
  • Andreoli, L., M. Fredi, C. Nalli, et al. (2013). Antiphospholipid antibodies mediate autoimmunity against dying cells. Autoimmunity. 46: 302–306
  • Lo, Y. M., J. Zhang, T. N. Leung, et al. (1999). Rapid clearance of fetal DNA from maternal plasma. Am. J. Hum. Gene. 64: 218–224
  • Derksen, R. H., M. A. Khamashta, and D. W. Branch. (2004). Management of the obstetric antiphospholipid syndrome. Arthritis Rheum. 50: 1028–1039
  • Tempfer, C. B., C. Kurz, E. K. Bentz, et al. (2006). A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study. Fertil. Steril. 86: 145–148
  • Danza, A., G. Ruiz-Irastorza, and M. Khamashta. (2012). Antiphospohlipid syndrome in obstetrics. Best Pract. Res. Clin. Obstet. Gynaecol. 26: 65–76
  • Odiari, E. A., M. J. Mulla, A. K. Sfakianaki, et al. (2012). Pravastatin does not prevent antiphospholipid antibody-mediated changes in human first trimester trophoblast function. Hum. Reprod. 27: 2933–2940

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.